nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—epilepsy syndrome	0.172	1	CbGaD
Terazosin—ABCB1—Levetiracetam—epilepsy syndrome	0.0543	0.208	CbGbCtD
Terazosin—ABCB1—Clobazam—epilepsy syndrome	0.0376	0.144	CbGbCtD
Terazosin—ABCB1—Lamotrigine—epilepsy syndrome	0.0362	0.139	CbGbCtD
Terazosin—ABCB1—Carbamazepine—epilepsy syndrome	0.0312	0.12	CbGbCtD
Terazosin—ABCB1—Phenytoin—epilepsy syndrome	0.028	0.107	CbGbCtD
Terazosin—ABCB1—Phenobarbital—epilepsy syndrome	0.0249	0.0957	CbGbCtD
Terazosin—ABCB1—Midazolam—epilepsy syndrome	0.0246	0.0944	CbGbCtD
Terazosin—ABCB1—Diazepam—epilepsy syndrome	0.0236	0.0907	CbGbCtD
Terazosin—KCNH6—ganglion—epilepsy syndrome	0.00692	0.129	CbGeAlD
Terazosin—KCNH6—forebrain—epilepsy syndrome	0.0029	0.054	CbGeAlD
Terazosin—KCNH6—telencephalon—epilepsy syndrome	0.00267	0.0496	CbGeAlD
Terazosin—KCNH7—head—epilepsy syndrome	0.00233	0.0434	CbGeAlD
Terazosin—KCNH7—nervous system—epilepsy syndrome	0.00221	0.0411	CbGeAlD
Terazosin—KCNH7—central nervous system—epilepsy syndrome	0.00213	0.0396	CbGeAlD
Terazosin—KCNH7—cerebellum—epilepsy syndrome	0.00208	0.0387	CbGeAlD
Terazosin—KCNH7—brain—epilepsy syndrome	0.00169	0.0314	CbGeAlD
Terazosin—ADRA1A—hindbrain—epilepsy syndrome	0.00167	0.031	CbGeAlD
Terazosin—KCNH6—head—epilepsy syndrome	0.00166	0.0309	CbGeAlD
Terazosin—ADRA1D—forebrain—epilepsy syndrome	0.00161	0.0299	CbGeAlD
Terazosin—KCNH6—nervous system—epilepsy syndrome	0.00158	0.0293	CbGeAlD
Terazosin—KCNH6—central nervous system—epilepsy syndrome	0.00152	0.0282	CbGeAlD
Terazosin—ADRA1D—telencephalon—epilepsy syndrome	0.00148	0.0275	CbGeAlD
Terazosin—KCNH6—brain—epilepsy syndrome	0.0012	0.0224	CbGeAlD
Terazosin—ADRA1A—brainstem—epilepsy syndrome	0.000957	0.0178	CbGeAlD
Terazosin—ADRA1B—head—epilepsy syndrome	0.000941	0.0175	CbGeAlD
Terazosin—Doxazosin—ADRA2A—epilepsy syndrome	0.000936	0.21	CrCbGaD
Terazosin—ADRA1A—forebrain—epilepsy syndrome	0.000924	0.0172	CbGeAlD
Terazosin—ADRA1D—head—epilepsy syndrome	0.000921	0.0171	CbGeAlD
Terazosin—ADRA1B—nervous system—epilepsy syndrome	0.000892	0.0166	CbGeAlD
Terazosin—KCNH2—forebrain—epilepsy syndrome	0.000892	0.0166	CbGeAlD
Terazosin—ADRA1D—nervous system—epilepsy syndrome	0.000873	0.0162	CbGeAlD
Terazosin—Prazosin—ADRA2A—epilepsy syndrome	0.000862	0.193	CrCbGaD
Terazosin—ADRA1B—central nervous system—epilepsy syndrome	0.000859	0.016	CbGeAlD
Terazosin—ADRA1A—telencephalon—epilepsy syndrome	0.000849	0.0158	CbGeAlD
Terazosin—ADRA1D—central nervous system—epilepsy syndrome	0.00084	0.0156	CbGeAlD
Terazosin—KCNH2—telencephalon—epilepsy syndrome	0.00082	0.0153	CbGeAlD
Terazosin—Prazosin—ABCG2—epilepsy syndrome	0.000793	0.178	CrCbGaD
Terazosin—ADRA1B—brain—epilepsy syndrome	0.000682	0.0127	CbGeAlD
Terazosin—Doxazosin—CYP2C19—epilepsy syndrome	0.000677	0.152	CrCbGaD
Terazosin—ADRA1D—brain—epilepsy syndrome	0.000667	0.0124	CbGeAlD
Terazosin—KCNH2—medulla oblongata—epilepsy syndrome	0.000644	0.012	CbGeAlD
Terazosin—KCNH2—midbrain—epilepsy syndrome	0.000589	0.011	CbGeAlD
Terazosin—KCNH2—spinal cord—epilepsy syndrome	0.000575	0.0107	CbGeAlD
Terazosin—ADRA1A—head—epilepsy syndrome	0.000529	0.00983	CbGeAlD
Terazosin—KCNH2—head—epilepsy syndrome	0.000511	0.0095	CbGeAlD
Terazosin—Doxazosin—CYP2D6—epilepsy syndrome	0.000502	0.113	CrCbGaD
Terazosin—ADRA1A—nervous system—epilepsy syndrome	0.000501	0.00932	CbGeAlD
Terazosin—KCNH2—nervous system—epilepsy syndrome	0.000484	0.009	CbGeAlD
Terazosin—ADRA1A—central nervous system—epilepsy syndrome	0.000483	0.00898	CbGeAlD
Terazosin—ADRA1A—cerebellum—epilepsy syndrome	0.000472	0.00877	CbGeAlD
Terazosin—KCNH2—central nervous system—epilepsy syndrome	0.000466	0.00867	CbGeAlD
Terazosin—KCNH2—cerebellum—epilepsy syndrome	0.000456	0.00847	CbGeAlD
Terazosin—ABCB1—forebrain—epilepsy syndrome	0.000391	0.00728	CbGeAlD
Terazosin—ADRA1A—brain—epilepsy syndrome	0.000383	0.00713	CbGeAlD
Terazosin—KCNH2—brain—epilepsy syndrome	0.00037	0.00688	CbGeAlD
Terazosin—ABCB1—telencephalon—epilepsy syndrome	0.00036	0.00669	CbGeAlD
Terazosin—Doxazosin—ABCB1—epilepsy syndrome	0.000358	0.0804	CrCbGaD
Terazosin—Prazosin—ABCB1—epilepsy syndrome	0.00033	0.074	CrCbGaD
Terazosin—ABCB1—medulla oblongata—epilepsy syndrome	0.000283	0.00526	CbGeAlD
Terazosin—ABCB1—midbrain—epilepsy syndrome	0.000258	0.00481	CbGeAlD
Terazosin—ABCB1—spinal cord—epilepsy syndrome	0.000252	0.00469	CbGeAlD
Terazosin—ABCB1—head—epilepsy syndrome	0.000224	0.00417	CbGeAlD
Terazosin—ABCB1—nervous system—epilepsy syndrome	0.000212	0.00395	CbGeAlD
Terazosin—ABCB1—central nervous system—epilepsy syndrome	0.000205	0.0038	CbGeAlD
Terazosin—ABCB1—cerebellum—epilepsy syndrome	0.0002	0.00372	CbGeAlD
Terazosin—ABCB1—brain—epilepsy syndrome	0.000162	0.00302	CbGeAlD
Terazosin—Asthenia—Phenytoin—epilepsy syndrome	0.000104	0.000343	CcSEcCtD
Terazosin—Nausea—Midazolam—epilepsy syndrome	0.000104	0.000342	CcSEcCtD
Terazosin—Tachycardia—Valproic Acid—epilepsy syndrome	0.000104	0.000342	CcSEcCtD
Terazosin—Diarrhoea—Zonisamide—epilepsy syndrome	0.000104	0.000342	CcSEcCtD
Terazosin—Pharyngitis—Topiramate—epilepsy syndrome	0.000104	0.000341	CcSEcCtD
Terazosin—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000104	0.000341	CcSEcCtD
Terazosin—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000104	0.000341	CcSEcCtD
Terazosin—Pruritus—Clonazepam—epilepsy syndrome	0.000103	0.00034	CcSEcCtD
Terazosin—Vomiting—Vigabatrin—epilepsy syndrome	0.000103	0.00034	CcSEcCtD
Terazosin—Oedema peripheral—Topiramate—epilepsy syndrome	0.000103	0.000339	CcSEcCtD
Terazosin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000103	0.000339	CcSEcCtD
Terazosin—Cough—Pregabalin—epilepsy syndrome	0.000103	0.000339	CcSEcCtD
Terazosin—Pruritus—Phenytoin—epilepsy syndrome	0.000103	0.000338	CcSEcCtD
Terazosin—Nausea—Levetiracetam—epilepsy syndrome	0.000103	0.000338	CcSEcCtD
Terazosin—Rash—Vigabatrin—epilepsy syndrome	0.000103	0.000337	CcSEcCtD
Terazosin—Dizziness—Felbamate—epilepsy syndrome	0.000103	0.000337	CcSEcCtD
Terazosin—Dermatitis—Vigabatrin—epilepsy syndrome	0.000102	0.000337	CcSEcCtD
Terazosin—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000102	0.000336	CcSEcCtD
Terazosin—Convulsion—Pregabalin—epilepsy syndrome	0.000102	0.000336	CcSEcCtD
Terazosin—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000102	0.000336	CcSEcCtD
Terazosin—Vision blurred—Gabapentin—epilepsy syndrome	0.000102	0.000335	CcSEcCtD
Terazosin—Headache—Vigabatrin—epilepsy syndrome	0.000102	0.000335	CcSEcCtD
Terazosin—Vomiting—Diazepam—epilepsy syndrome	0.000102	0.000335	CcSEcCtD
Terazosin—Anorexia—Valproic Acid—epilepsy syndrome	0.000102	0.000334	CcSEcCtD
Terazosin—Tremor—Gabapentin—epilepsy syndrome	0.000101	0.000333	CcSEcCtD
Terazosin—Rash—Diazepam—epilepsy syndrome	0.000101	0.000332	CcSEcCtD
Terazosin—Dermatitis—Diazepam—epilepsy syndrome	0.000101	0.000332	CcSEcCtD
Terazosin—Visual impairment—Topiramate—epilepsy syndrome	0.000101	0.000331	CcSEcCtD
Terazosin—Myalgia—Pregabalin—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Arthralgia—Pregabalin—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Chest pain—Pregabalin—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Dizziness—Zonisamide—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Headache—Diazepam—epilepsy syndrome	0.0001	0.00033	CcSEcCtD
Terazosin—Anxiety—Pregabalin—epilepsy syndrome	0.0001	0.000329	CcSEcCtD
Terazosin—Diarrhoea—Clonazepam—epilepsy syndrome	0.0001	0.000329	CcSEcCtD
Terazosin—Hypotension—Valproic Acid—epilepsy syndrome	9.95e-05	0.000327	CcSEcCtD
Terazosin—Asthenia—Carbamazepine—epilepsy syndrome	9.95e-05	0.000327	CcSEcCtD
Terazosin—Diarrhoea—Phenytoin—epilepsy syndrome	9.94e-05	0.000327	CcSEcCtD
Terazosin—Discomfort—Pregabalin—epilepsy syndrome	9.92e-05	0.000326	CcSEcCtD
Terazosin—Nausea—Fosphenytoin—epilepsy syndrome	9.91e-05	0.000326	CcSEcCtD
Terazosin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.89e-05	0.000325	CcSEcCtD
Terazosin—Angioedema—Gabapentin—epilepsy syndrome	9.88e-05	0.000325	CcSEcCtD
Terazosin—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.87e-05	0.000325	CcSEcCtD
Terazosin—Vomiting—Felbamate—epilepsy syndrome	9.86e-05	0.000324	CcSEcCtD
Terazosin—Dry mouth—Pregabalin—epilepsy syndrome	9.82e-05	0.000323	CcSEcCtD
Terazosin—Pruritus—Carbamazepine—epilepsy syndrome	9.81e-05	0.000323	CcSEcCtD
Terazosin—Rash—Felbamate—epilepsy syndrome	9.77e-05	0.000322	CcSEcCtD
Terazosin—Eye disorder—Topiramate—epilepsy syndrome	9.77e-05	0.000321	CcSEcCtD
Terazosin—Dermatitis—Felbamate—epilepsy syndrome	9.77e-05	0.000321	CcSEcCtD
Terazosin—Malaise—Gabapentin—epilepsy syndrome	9.75e-05	0.000321	CcSEcCtD
Terazosin—Tinnitus—Topiramate—epilepsy syndrome	9.75e-05	0.000321	CcSEcCtD
Terazosin—Vertigo—Gabapentin—epilepsy syndrome	9.72e-05	0.00032	CcSEcCtD
Terazosin—Headache—Felbamate—epilepsy syndrome	9.71e-05	0.000319	CcSEcCtD
Terazosin—Confusional state—Pregabalin—epilepsy syndrome	9.71e-05	0.000319	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.7e-05	0.000319	CcSEcCtD
Terazosin—Syncope—Gabapentin—epilepsy syndrome	9.7e-05	0.000319	CcSEcCtD
Terazosin—Dizziness—Clonazepam—epilepsy syndrome	9.67e-05	0.000318	CcSEcCtD
Terazosin—Nausea—Vigabatrin—epilepsy syndrome	9.66e-05	0.000318	CcSEcCtD
Terazosin—Vomiting—Zonisamide—epilepsy syndrome	9.65e-05	0.000317	CcSEcCtD
Terazosin—Insomnia—Valproic Acid—epilepsy syndrome	9.63e-05	0.000317	CcSEcCtD
Terazosin—Oedema—Pregabalin—epilepsy syndrome	9.63e-05	0.000317	CcSEcCtD
Terazosin—Anaphylactic shock—Pregabalin—epilepsy syndrome	9.63e-05	0.000317	CcSEcCtD
Terazosin—Asthenia—Lamotrigine—epilepsy syndrome	9.62e-05	0.000316	CcSEcCtD
Terazosin—Dizziness—Phenytoin—epilepsy syndrome	9.61e-05	0.000316	CcSEcCtD
Terazosin—Rash—Zonisamide—epilepsy syndrome	9.57e-05	0.000315	CcSEcCtD
Terazosin—Paraesthesia—Valproic Acid—epilepsy syndrome	9.56e-05	0.000315	CcSEcCtD
Terazosin—Palpitations—Gabapentin—epilepsy syndrome	9.56e-05	0.000314	CcSEcCtD
Terazosin—Dermatitis—Zonisamide—epilepsy syndrome	9.56e-05	0.000314	CcSEcCtD
Terazosin—Dizziness—Oxcarbazepine—epilepsy syndrome	9.56e-05	0.000314	CcSEcCtD
Terazosin—Nausea—Diazepam—epilepsy syndrome	9.51e-05	0.000313	CcSEcCtD
Terazosin—Loss of consciousness—Gabapentin—epilepsy syndrome	9.51e-05	0.000313	CcSEcCtD
Terazosin—Headache—Zonisamide—epilepsy syndrome	9.51e-05	0.000313	CcSEcCtD
Terazosin—Dyspnoea—Valproic Acid—epilepsy syndrome	9.49e-05	0.000312	CcSEcCtD
Terazosin—Diarrhoea—Carbamazepine—epilepsy syndrome	9.49e-05	0.000312	CcSEcCtD
Terazosin—Pruritus—Lamotrigine—epilepsy syndrome	9.48e-05	0.000312	CcSEcCtD
Terazosin—Shock—Pregabalin—epilepsy syndrome	9.47e-05	0.000312	CcSEcCtD
Terazosin—Somnolence—Valproic Acid—epilepsy syndrome	9.47e-05	0.000311	CcSEcCtD
Terazosin—Cough—Gabapentin—epilepsy syndrome	9.44e-05	0.000311	CcSEcCtD
Terazosin—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.43e-05	0.00031	CcSEcCtD
Terazosin—Tachycardia—Pregabalin—epilepsy syndrome	9.4e-05	0.000309	CcSEcCtD
Terazosin—Dyspepsia—Valproic Acid—epilepsy syndrome	9.37e-05	0.000308	CcSEcCtD
Terazosin—Convulsion—Gabapentin—epilepsy syndrome	9.37e-05	0.000308	CcSEcCtD
Terazosin—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.31e-05	0.000306	CcSEcCtD
Terazosin—Vomiting—Clonazepam—epilepsy syndrome	9.3e-05	0.000306	CcSEcCtD
Terazosin—Decreased appetite—Valproic Acid—epilepsy syndrome	9.26e-05	0.000305	CcSEcCtD
Terazosin—Vomiting—Phenytoin—epilepsy syndrome	9.24e-05	0.000304	CcSEcCtD
Terazosin—Rash—Clonazepam—epilepsy syndrome	9.22e-05	0.000303	CcSEcCtD
Terazosin—Dermatitis—Clonazepam—epilepsy syndrome	9.21e-05	0.000303	CcSEcCtD
Terazosin—Arthralgia—Gabapentin—epilepsy syndrome	9.21e-05	0.000303	CcSEcCtD
Terazosin—Myalgia—Gabapentin—epilepsy syndrome	9.21e-05	0.000303	CcSEcCtD
Terazosin—Chest pain—Gabapentin—epilepsy syndrome	9.21e-05	0.000303	CcSEcCtD
Terazosin—Nausea—Felbamate—epilepsy syndrome	9.21e-05	0.000303	CcSEcCtD
Terazosin—Vomiting—Oxcarbazepine—epilepsy syndrome	9.19e-05	0.000302	CcSEcCtD
Terazosin—Fatigue—Valproic Acid—epilepsy syndrome	9.18e-05	0.000302	CcSEcCtD
Terazosin—Anxiety—Gabapentin—epilepsy syndrome	9.18e-05	0.000302	CcSEcCtD
Terazosin—Anorexia—Pregabalin—epilepsy syndrome	9.18e-05	0.000302	CcSEcCtD
Terazosin—Dizziness—Carbamazepine—epilepsy syndrome	9.17e-05	0.000302	CcSEcCtD
Terazosin—Diarrhoea—Lamotrigine—epilepsy syndrome	9.17e-05	0.000302	CcSEcCtD
Terazosin—Headache—Clonazepam—epilepsy syndrome	9.16e-05	0.000301	CcSEcCtD
Terazosin—Rash—Phenytoin—epilepsy syndrome	9.16e-05	0.000301	CcSEcCtD
Terazosin—Dermatitis—Phenytoin—epilepsy syndrome	9.15e-05	0.000301	CcSEcCtD
Terazosin—Rash—Oxcarbazepine—epilepsy syndrome	9.11e-05	0.0003	CcSEcCtD
Terazosin—Pain—Valproic Acid—epilepsy syndrome	9.11e-05	0.0003	CcSEcCtD
Terazosin—Constipation—Valproic Acid—epilepsy syndrome	9.11e-05	0.0003	CcSEcCtD
Terazosin—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.1e-05	0.000299	CcSEcCtD
Terazosin—Headache—Phenytoin—epilepsy syndrome	9.1e-05	0.000299	CcSEcCtD
Terazosin—Malnutrition—Topiramate—epilepsy syndrome	9.1e-05	0.000299	CcSEcCtD
Terazosin—Discomfort—Gabapentin—epilepsy syndrome	9.1e-05	0.000299	CcSEcCtD
Terazosin—Headache—Oxcarbazepine—epilepsy syndrome	9.05e-05	0.000298	CcSEcCtD
Terazosin—Nausea—Zonisamide—epilepsy syndrome	9.01e-05	0.000296	CcSEcCtD
Terazosin—Dry mouth—Gabapentin—epilepsy syndrome	9.01e-05	0.000296	CcSEcCtD
Terazosin—Hypotension—Pregabalin—epilepsy syndrome	9e-05	0.000296	CcSEcCtD
Terazosin—Flatulence—Topiramate—epilepsy syndrome	8.97e-05	0.000295	CcSEcCtD
Terazosin—Tension—Topiramate—epilepsy syndrome	8.93e-05	0.000294	CcSEcCtD
Terazosin—Dysgeusia—Topiramate—epilepsy syndrome	8.91e-05	0.000293	CcSEcCtD
Terazosin—Confusional state—Gabapentin—epilepsy syndrome	8.9e-05	0.000293	CcSEcCtD
Terazosin—Dizziness—Lamotrigine—epilepsy syndrome	8.86e-05	0.000292	CcSEcCtD
Terazosin—Nervousness—Topiramate—epilepsy syndrome	8.84e-05	0.000291	CcSEcCtD
Terazosin—Anaphylactic shock—Gabapentin—epilepsy syndrome	8.83e-05	0.00029	CcSEcCtD
Terazosin—Oedema—Gabapentin—epilepsy syndrome	8.83e-05	0.00029	CcSEcCtD
Terazosin—Vomiting—Carbamazepine—epilepsy syndrome	8.82e-05	0.00029	CcSEcCtD
Terazosin—Back pain—Topiramate—epilepsy syndrome	8.8e-05	0.00029	CcSEcCtD
Terazosin—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.78e-05	0.000289	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.77e-05	0.000289	CcSEcCtD
Terazosin—Rash—Carbamazepine—epilepsy syndrome	8.74e-05	0.000288	CcSEcCtD
Terazosin—Dermatitis—Carbamazepine—epilepsy syndrome	8.74e-05	0.000287	CcSEcCtD
Terazosin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.71e-05	0.000286	CcSEcCtD
Terazosin—Insomnia—Pregabalin—epilepsy syndrome	8.71e-05	0.000286	CcSEcCtD
Terazosin—Nausea—Clonazepam—epilepsy syndrome	8.69e-05	0.000286	CcSEcCtD
Terazosin—Headache—Carbamazepine—epilepsy syndrome	8.69e-05	0.000286	CcSEcCtD
Terazosin—Shock—Gabapentin—epilepsy syndrome	8.69e-05	0.000286	CcSEcCtD
Terazosin—Paraesthesia—Pregabalin—epilepsy syndrome	8.65e-05	0.000284	CcSEcCtD
Terazosin—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.64e-05	0.000284	CcSEcCtD
Terazosin—Nausea—Phenytoin—epilepsy syndrome	8.63e-05	0.000284	CcSEcCtD
Terazosin—Tachycardia—Gabapentin—epilepsy syndrome	8.62e-05	0.000283	CcSEcCtD
Terazosin—Dyspnoea—Pregabalin—epilepsy syndrome	8.58e-05	0.000282	CcSEcCtD
Terazosin—Nausea—Oxcarbazepine—epilepsy syndrome	8.58e-05	0.000282	CcSEcCtD
Terazosin—Vision blurred—Topiramate—epilepsy syndrome	8.58e-05	0.000282	CcSEcCtD
Terazosin—Somnolence—Pregabalin—epilepsy syndrome	8.56e-05	0.000282	CcSEcCtD
Terazosin—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.53e-05	0.000281	CcSEcCtD
Terazosin—Tremor—Topiramate—epilepsy syndrome	8.53e-05	0.00028	CcSEcCtD
Terazosin—Vomiting—Lamotrigine—epilepsy syndrome	8.52e-05	0.00028	CcSEcCtD
Terazosin—Rash—Lamotrigine—epilepsy syndrome	8.45e-05	0.000278	CcSEcCtD
Terazosin—Ill-defined disorder—Topiramate—epilepsy syndrome	8.44e-05	0.000278	CcSEcCtD
Terazosin—Dermatitis—Lamotrigine—epilepsy syndrome	8.44e-05	0.000278	CcSEcCtD
Terazosin—Abdominal pain—Valproic Acid—epilepsy syndrome	8.42e-05	0.000277	CcSEcCtD
Terazosin—Body temperature increased—Valproic Acid—epilepsy syndrome	8.42e-05	0.000277	CcSEcCtD
Terazosin—Anorexia—Gabapentin—epilepsy syndrome	8.42e-05	0.000277	CcSEcCtD
Terazosin—Headache—Lamotrigine—epilepsy syndrome	8.4e-05	0.000276	CcSEcCtD
Terazosin—Decreased appetite—Pregabalin—epilepsy syndrome	8.37e-05	0.000275	CcSEcCtD
Terazosin—Fatigue—Pregabalin—epilepsy syndrome	8.3e-05	0.000273	CcSEcCtD
Terazosin—Hypotension—Gabapentin—epilepsy syndrome	8.25e-05	0.000271	CcSEcCtD
Terazosin—Nausea—Carbamazepine—epilepsy syndrome	8.24e-05	0.000271	CcSEcCtD
Terazosin—Constipation—Pregabalin—epilepsy syndrome	8.23e-05	0.000271	CcSEcCtD
Terazosin—Pain—Pregabalin—epilepsy syndrome	8.23e-05	0.000271	CcSEcCtD
Terazosin—Malaise—Topiramate—epilepsy syndrome	8.21e-05	0.00027	CcSEcCtD
Terazosin—Vertigo—Topiramate—epilepsy syndrome	8.18e-05	0.000269	CcSEcCtD
Terazosin—Syncope—Topiramate—epilepsy syndrome	8.16e-05	0.000268	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.04e-05	0.000265	CcSEcCtD
Terazosin—Palpitations—Topiramate—epilepsy syndrome	8.04e-05	0.000265	CcSEcCtD
Terazosin—Loss of consciousness—Topiramate—epilepsy syndrome	8e-05	0.000263	CcSEcCtD
Terazosin—Insomnia—Gabapentin—epilepsy syndrome	7.98e-05	0.000263	CcSEcCtD
Terazosin—Nausea—Lamotrigine—epilepsy syndrome	7.96e-05	0.000262	CcSEcCtD
Terazosin—Cough—Topiramate—epilepsy syndrome	7.94e-05	0.000261	CcSEcCtD
Terazosin—Feeling abnormal—Pregabalin—epilepsy syndrome	7.93e-05	0.000261	CcSEcCtD
Terazosin—Paraesthesia—Gabapentin—epilepsy syndrome	7.93e-05	0.000261	CcSEcCtD
Terazosin—Convulsion—Topiramate—epilepsy syndrome	7.89e-05	0.000259	CcSEcCtD
Terazosin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.87e-05	0.000259	CcSEcCtD
Terazosin—Dyspnoea—Gabapentin—epilepsy syndrome	7.87e-05	0.000259	CcSEcCtD
Terazosin—Somnolence—Gabapentin—epilepsy syndrome	7.85e-05	0.000258	CcSEcCtD
Terazosin—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.85e-05	0.000258	CcSEcCtD
Terazosin—Dyspepsia—Gabapentin—epilepsy syndrome	7.77e-05	0.000256	CcSEcCtD
Terazosin—Chest pain—Topiramate—epilepsy syndrome	7.75e-05	0.000255	CcSEcCtD
Terazosin—Myalgia—Topiramate—epilepsy syndrome	7.75e-05	0.000255	CcSEcCtD
Terazosin—Arthralgia—Topiramate—epilepsy syndrome	7.75e-05	0.000255	CcSEcCtD
Terazosin—Anxiety—Topiramate—epilepsy syndrome	7.72e-05	0.000254	CcSEcCtD
Terazosin—Decreased appetite—Gabapentin—epilepsy syndrome	7.67e-05	0.000252	CcSEcCtD
Terazosin—Discomfort—Topiramate—epilepsy syndrome	7.66e-05	0.000252	CcSEcCtD
Terazosin—Asthenia—Valproic Acid—epilepsy syndrome	7.64e-05	0.000251	CcSEcCtD
Terazosin—Fatigue—Gabapentin—epilepsy syndrome	7.61e-05	0.00025	CcSEcCtD
Terazosin—Abdominal pain—Pregabalin—epilepsy syndrome	7.61e-05	0.00025	CcSEcCtD
Terazosin—Body temperature increased—Pregabalin—epilepsy syndrome	7.61e-05	0.00025	CcSEcCtD
Terazosin—Dry mouth—Topiramate—epilepsy syndrome	7.58e-05	0.000249	CcSEcCtD
Terazosin—Pain—Gabapentin—epilepsy syndrome	7.55e-05	0.000248	CcSEcCtD
Terazosin—Constipation—Gabapentin—epilepsy syndrome	7.55e-05	0.000248	CcSEcCtD
Terazosin—Pruritus—Valproic Acid—epilepsy syndrome	7.53e-05	0.000248	CcSEcCtD
Terazosin—Confusional state—Topiramate—epilepsy syndrome	7.49e-05	0.000246	CcSEcCtD
Terazosin—Oedema—Topiramate—epilepsy syndrome	7.43e-05	0.000244	CcSEcCtD
Terazosin—Shock—Topiramate—epilepsy syndrome	7.31e-05	0.00024	CcSEcCtD
Terazosin—Diarrhoea—Valproic Acid—epilepsy syndrome	7.29e-05	0.00024	CcSEcCtD
Terazosin—Feeling abnormal—Gabapentin—epilepsy syndrome	7.28e-05	0.000239	CcSEcCtD
Terazosin—Thrombocytopenia—Topiramate—epilepsy syndrome	7.27e-05	0.000239	CcSEcCtD
Terazosin—Tachycardia—Topiramate—epilepsy syndrome	7.25e-05	0.000238	CcSEcCtD
Terazosin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.22e-05	0.000237	CcSEcCtD
Terazosin—Hyperhidrosis—Topiramate—epilepsy syndrome	7.18e-05	0.000236	CcSEcCtD
Terazosin—Hypersensitivity—Pregabalin—epilepsy syndrome	7.09e-05	0.000233	CcSEcCtD
Terazosin—Anorexia—Topiramate—epilepsy syndrome	7.08e-05	0.000233	CcSEcCtD
Terazosin—Dizziness—Valproic Acid—epilepsy syndrome	7.04e-05	0.000232	CcSEcCtD
Terazosin—Abdominal pain—Gabapentin—epilepsy syndrome	6.98e-05	0.00023	CcSEcCtD
Terazosin—Body temperature increased—Gabapentin—epilepsy syndrome	6.98e-05	0.00023	CcSEcCtD
Terazosin—Hypotension—Topiramate—epilepsy syndrome	6.94e-05	0.000228	CcSEcCtD
Terazosin—Asthenia—Pregabalin—epilepsy syndrome	6.91e-05	0.000227	CcSEcCtD
Terazosin—Pruritus—Pregabalin—epilepsy syndrome	6.81e-05	0.000224	CcSEcCtD
Terazosin—Vomiting—Valproic Acid—epilepsy syndrome	6.77e-05	0.000223	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.77e-05	0.000223	CcSEcCtD
Terazosin—Insomnia—Topiramate—epilepsy syndrome	6.72e-05	0.000221	CcSEcCtD
Terazosin—Rash—Valproic Acid—epilepsy syndrome	6.71e-05	0.000221	CcSEcCtD
Terazosin—Dermatitis—Valproic Acid—epilepsy syndrome	6.71e-05	0.000221	CcSEcCtD
Terazosin—Headache—Valproic Acid—epilepsy syndrome	6.67e-05	0.000219	CcSEcCtD
Terazosin—Paraesthesia—Topiramate—epilepsy syndrome	6.67e-05	0.000219	CcSEcCtD
Terazosin—Dyspnoea—Topiramate—epilepsy syndrome	6.62e-05	0.000218	CcSEcCtD
Terazosin—Somnolence—Topiramate—epilepsy syndrome	6.6e-05	0.000217	CcSEcCtD
Terazosin—Diarrhoea—Pregabalin—epilepsy syndrome	6.59e-05	0.000217	CcSEcCtD
Terazosin—Dyspepsia—Topiramate—epilepsy syndrome	6.54e-05	0.000215	CcSEcCtD
Terazosin—Hypersensitivity—Gabapentin—epilepsy syndrome	6.5e-05	0.000214	CcSEcCtD
Terazosin—Decreased appetite—Topiramate—epilepsy syndrome	6.46e-05	0.000212	CcSEcCtD
Terazosin—Fatigue—Topiramate—epilepsy syndrome	6.4e-05	0.000211	CcSEcCtD
Terazosin—Dizziness—Pregabalin—epilepsy syndrome	6.37e-05	0.000209	CcSEcCtD
Terazosin—Constipation—Topiramate—epilepsy syndrome	6.35e-05	0.000209	CcSEcCtD
Terazosin—Pain—Topiramate—epilepsy syndrome	6.35e-05	0.000209	CcSEcCtD
Terazosin—Asthenia—Gabapentin—epilepsy syndrome	6.33e-05	0.000208	CcSEcCtD
Terazosin—Nausea—Valproic Acid—epilepsy syndrome	6.33e-05	0.000208	CcSEcCtD
Terazosin—Pruritus—Gabapentin—epilepsy syndrome	6.25e-05	0.000205	CcSEcCtD
Terazosin—Vomiting—Pregabalin—epilepsy syndrome	6.12e-05	0.000201	CcSEcCtD
Terazosin—Feeling abnormal—Topiramate—epilepsy syndrome	6.12e-05	0.000201	CcSEcCtD
Terazosin—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.07e-05	0.0002	CcSEcCtD
Terazosin—Rash—Pregabalin—epilepsy syndrome	6.07e-05	0.0002	CcSEcCtD
Terazosin—Dermatitis—Pregabalin—epilepsy syndrome	6.06e-05	0.000199	CcSEcCtD
Terazosin—Diarrhoea—Gabapentin—epilepsy syndrome	6.04e-05	0.000199	CcSEcCtD
Terazosin—Headache—Pregabalin—epilepsy syndrome	6.03e-05	0.000198	CcSEcCtD
Terazosin—Body temperature increased—Topiramate—epilepsy syndrome	5.87e-05	0.000193	CcSEcCtD
Terazosin—Abdominal pain—Topiramate—epilepsy syndrome	5.87e-05	0.000193	CcSEcCtD
Terazosin—Dizziness—Gabapentin—epilepsy syndrome	5.84e-05	0.000192	CcSEcCtD
Terazosin—Nausea—Pregabalin—epilepsy syndrome	5.72e-05	0.000188	CcSEcCtD
Terazosin—Vomiting—Gabapentin—epilepsy syndrome	5.61e-05	0.000185	CcSEcCtD
Terazosin—Rash—Gabapentin—epilepsy syndrome	5.57e-05	0.000183	CcSEcCtD
Terazosin—Dermatitis—Gabapentin—epilepsy syndrome	5.56e-05	0.000183	CcSEcCtD
Terazosin—Headache—Gabapentin—epilepsy syndrome	5.53e-05	0.000182	CcSEcCtD
Terazosin—Hypersensitivity—Topiramate—epilepsy syndrome	5.47e-05	0.00018	CcSEcCtD
Terazosin—Asthenia—Topiramate—epilepsy syndrome	5.33e-05	0.000175	CcSEcCtD
Terazosin—Pruritus—Topiramate—epilepsy syndrome	5.25e-05	0.000173	CcSEcCtD
Terazosin—Nausea—Gabapentin—epilepsy syndrome	5.24e-05	0.000172	CcSEcCtD
Terazosin—Diarrhoea—Topiramate—epilepsy syndrome	5.08e-05	0.000167	CcSEcCtD
Terazosin—Dizziness—Topiramate—epilepsy syndrome	4.91e-05	0.000162	CcSEcCtD
Terazosin—Vomiting—Topiramate—epilepsy syndrome	4.72e-05	0.000155	CcSEcCtD
Terazosin—Rash—Topiramate—epilepsy syndrome	4.68e-05	0.000154	CcSEcCtD
Terazosin—Dermatitis—Topiramate—epilepsy syndrome	4.68e-05	0.000154	CcSEcCtD
Terazosin—Headache—Topiramate—epilepsy syndrome	4.65e-05	0.000153	CcSEcCtD
Terazosin—Nausea—Topiramate—epilepsy syndrome	4.41e-05	0.000145	CcSEcCtD
Terazosin—ADRA1B—Signaling Pathways—GABBR1—epilepsy syndrome	1.05e-05	5.1e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HBEGF—epilepsy syndrome	1.04e-05	5.08e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCR5—epilepsy syndrome	1.04e-05	5.08e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.03e-05	5.03e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.03e-05	5.03e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CDC42—epilepsy syndrome	1.03e-05	5.01e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GFAP—epilepsy syndrome	1.03e-05	5.01e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAL—epilepsy syndrome	1.03e-05	5.01e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT3—epilepsy syndrome	1.02e-05	4.99e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—epilepsy syndrome	1.02e-05	4.98e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AVP—epilepsy syndrome	1.02e-05	4.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CHRM3—epilepsy syndrome	1.02e-05	4.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP2—epilepsy syndrome	1.02e-05	4.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GRM5—epilepsy syndrome	1.02e-05	4.96e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.01e-05	4.92e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HRH3—epilepsy syndrome	1e-05	4.89e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AVP—epilepsy syndrome	9.96e-06	4.85e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADSL—epilepsy syndrome	9.88e-06	4.82e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OPRM1—epilepsy syndrome	9.88e-06	4.82e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.85e-06	4.8e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTK2B—epilepsy syndrome	9.83e-06	4.79e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSC1—epilepsy syndrome	9.83e-06	4.79e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CX3CR1—epilepsy syndrome	9.75e-06	4.75e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GLUL—epilepsy syndrome	9.69e-06	4.73e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AGT—epilepsy syndrome	9.68e-06	4.72e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BDKRB1—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NTRK2—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CHRM2—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SST—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR2—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CX3CL1—epilepsy syndrome	9.56e-06	4.66e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CCR5—epilepsy syndrome	9.53e-06	4.65e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	9.51e-06	4.64e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DUSP6—epilepsy syndrome	9.48e-06	4.62e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	9.46e-06	4.61e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRA2A—epilepsy syndrome	9.35e-06	4.56e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CDC42—epilepsy syndrome	9.34e-06	4.55e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR3—epilepsy syndrome	9.33e-06	4.55e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.33e-06	4.55e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLAT—epilepsy syndrome	9.32e-06	4.54e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GABBR1—epilepsy syndrome	9.3e-06	4.53e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	9.21e-06	4.49e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPY—epilepsy syndrome	9.09e-06	4.43e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ATP2A2—epilepsy syndrome	9.09e-06	4.43e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AVP—epilepsy syndrome	9.04e-06	4.41e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—BDKRB2—epilepsy syndrome	8.99e-06	4.38e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL12—epilepsy syndrome	8.99e-06	4.38e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—POMC—epilepsy syndrome	8.97e-06	4.38e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PRKCB—epilepsy syndrome	8.95e-06	4.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HRH3—epilepsy syndrome	8.92e-06	4.35e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6ST—epilepsy syndrome	8.91e-06	4.34e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.9e-06	4.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AGT—epilepsy syndrome	8.85e-06	4.31e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.84e-06	4.31e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JUNB—epilepsy syndrome	8.82e-06	4.3e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CNR1—epilepsy syndrome	8.82e-06	4.3e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLCB1—epilepsy syndrome	8.79e-06	4.29e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OPRM1—epilepsy syndrome	8.78e-06	4.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL2—epilepsy syndrome	8.77e-06	4.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HSPB1—epilepsy syndrome	8.77e-06	4.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL3—epilepsy syndrome	8.77e-06	4.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CRH—epilepsy syndrome	8.77e-06	4.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—OXT—epilepsy syndrome	8.77e-06	4.28e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.76e-06	4.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCR5—epilepsy syndrome	8.65e-06	4.22e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AQP1—epilepsy syndrome	8.64e-06	4.21e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR7—epilepsy syndrome	8.61e-06	4.2e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—epilepsy syndrome	8.47e-06	4.13e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCR5—epilepsy syndrome	8.47e-06	4.13e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HBEGF—epilepsy syndrome	8.36e-06	4.07e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR3—epilepsy syndrome	8.29e-06	4.04e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	8.28e-06	4.04e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT3—epilepsy syndrome	8.2e-06	4e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.18e-06	3.99e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSC1—epilepsy syndrome	8.16e-06	3.98e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTK2B—epilepsy syndrome	8.16e-06	3.98e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—POMC—epilepsy syndrome	8.15e-06	3.97e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPY—epilepsy syndrome	8.08e-06	3.94e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ATP2A2—epilepsy syndrome	8.08e-06	3.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AGT—epilepsy syndrome	8.04e-06	3.92e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADAM10—epilepsy syndrome	8.01e-06	3.91e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL2—epilepsy syndrome	7.97e-06	3.89e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR2—epilepsy syndrome	7.93e-06	3.87e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NTRK2—epilepsy syndrome	7.93e-06	3.87e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SST—epilepsy syndrome	7.93e-06	3.87e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.9e-06	3.85e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DUSP6—epilepsy syndrome	7.86e-06	3.83e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AGT—epilepsy syndrome	7.86e-06	3.83e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.81e-06	3.81e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.81e-06	3.81e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HSPB1—epilepsy syndrome	7.79e-06	3.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CRH—epilepsy syndrome	7.79e-06	3.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL2—epilepsy syndrome	7.79e-06	3.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—OXT—epilepsy syndrome	7.79e-06	3.8e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL3—epilepsy syndrome	7.79e-06	3.8e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRA2A—epilepsy syndrome	7.76e-06	3.79e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLAT—epilepsy syndrome	7.73e-06	3.77e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCR5—epilepsy syndrome	7.69e-06	3.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—S100B—epilepsy syndrome	7.58e-06	3.69e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—epilepsy syndrome	7.52e-06	3.67e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SOCS3—epilepsy syndrome	7.5e-06	3.66e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CDC42—epilepsy syndrome	7.48e-06	3.65e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—BDKRB2—epilepsy syndrome	7.46e-06	3.64e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL12—epilepsy syndrome	7.46e-06	3.64e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—POMC—epilepsy syndrome	7.45e-06	3.63e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCB—epilepsy syndrome	7.43e-06	3.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6ST—epilepsy syndrome	7.4e-06	3.61e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CNR1—epilepsy syndrome	7.32e-06	3.57e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JUNB—epilepsy syndrome	7.32e-06	3.57e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLCB1—epilepsy syndrome	7.3e-06	3.56e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.26e-06	3.54e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTK2B—epilepsy syndrome	7.24e-06	3.53e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AVP—epilepsy syndrome	7.24e-06	3.53e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSC1—epilepsy syndrome	7.24e-06	3.53e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR7—epilepsy syndrome	7.14e-06	3.48e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AGT—epilepsy syndrome	7.14e-06	3.48e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	7.05e-06	3.44e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	7.05e-06	3.44e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	7.05e-06	3.44e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	6.99e-06	3.41e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HBEGF—epilepsy syndrome	6.94e-06	3.38e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	6.9e-06	3.36e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	6.87e-06	3.35e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HES1—epilepsy syndrome	6.85e-06	3.34e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT3—epilepsy syndrome	6.81e-06	3.32e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—epilepsy syndrome	6.76e-06	3.3e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FYN—epilepsy syndrome	6.66e-06	3.25e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADAM10—epilepsy syndrome	6.65e-06	3.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—H2AFX—epilepsy syndrome	6.64e-06	3.24e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MEF2C—epilepsy syndrome	6.63e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	6.63e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	6.63e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—epilepsy syndrome	6.62e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	6.62e-06	3.23e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	6.6e-06	3.22e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	6.57e-06	3.2e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	6.5e-06	3.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	6.5e-06	3.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	6.48e-06	3.16e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	6.4e-06	3.12e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	6.37e-06	3.11e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	6.35e-06	3.09e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	6.33e-06	3.09e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	6.29e-06	3.07e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	6.23e-06	3.04e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	6.21e-06	3.03e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.21e-06	3.03e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.17e-06	3.01e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	6.16e-06	3e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	6.16e-06	3e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	6.05e-06	2.95e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	6.03e-06	2.94e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	6.01e-06	2.93e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	6.01e-06	2.93e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	5.91e-06	2.88e-05	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.88e-06	2.87e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	5.88e-06	2.87e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	5.73e-06	2.79e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	5.72e-06	2.79e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	5.69e-06	2.77e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	5.6e-06	2.73e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	5.58e-06	2.72e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.57e-06	2.71e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	5.53e-06	2.7e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	5.53e-06	2.7e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	5.52e-06	2.69e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	5.51e-06	2.69e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	5.5e-06	2.68e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	5.49e-06	2.68e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	5.34e-06	2.6e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	5.32e-06	2.59e-05	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.31e-06	2.59e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.3e-06	2.58e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	5.29e-06	2.58e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.28e-06	2.57e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	5.26e-06	2.57e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	5.26e-06	2.56e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	5.11e-06	2.49e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	5.05e-06	2.46e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.03e-06	2.45e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	5e-06	2.44e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.98e-06	2.43e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TH—epilepsy syndrome	4.96e-06	2.42e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	4.91e-06	2.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	4.89e-06	2.39e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	4.88e-06	2.38e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	4.81e-06	2.35e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	4.75e-06	2.32e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	4.75e-06	2.31e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	4.72e-06	2.3e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	4.71e-06	2.3e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	4.67e-06	2.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	4.65e-06	2.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	4.56e-06	2.22e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	4.54e-06	2.21e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	4.44e-06	2.17e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	4.39e-06	2.14e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	4.37e-06	2.13e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	4.26e-06	2.08e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	4.22e-06	2.06e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	4.22e-06	2.06e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.14e-06	2.02e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	4.13e-06	2.01e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAT—epilepsy syndrome	4.09e-06	1.99e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	4.05e-06	1.97e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	4e-06	1.95e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	3.95e-06	1.93e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	3.91e-06	1.91e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	3.9e-06	1.9e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	3.88e-06	1.89e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	3.88e-06	1.89e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.7e-06	1.8e-05	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	3.6e-06	1.75e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	3.56e-06	1.74e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	3.55e-06	1.73e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	3.53e-06	1.72e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	3.47e-06	1.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	3.46e-06	1.69e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	3.37e-06	1.64e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	3.28e-06	1.6e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-06	1.59e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AGT—epilepsy syndrome	3.24e-06	1.58e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	3.22e-06	1.57e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—epilepsy syndrome	3.17e-06	1.55e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	3.14e-06	1.53e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	3.11e-06	1.51e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	3.02e-06	1.47e-05	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.99e-06	1.46e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	2.96e-06	1.44e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	2.91e-06	1.42e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	2.87e-06	1.4e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	2.86e-06	1.39e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	2.8e-06	1.36e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—epilepsy syndrome	2.73e-06	1.33e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	2.71e-06	1.32e-05	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.65e-06	1.29e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	2.63e-06	1.28e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	2.58e-06	1.26e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	2.55e-06	1.24e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	2.51e-06	1.22e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—epilepsy syndrome	2.49e-06	1.21e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	2.48e-06	1.21e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	2.41e-06	1.17e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	2.29e-06	1.12e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	2.23e-06	1.09e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.18e-06	1.06e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-06	9.41e-06	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	1.6e-06	7.81e-06	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	6.94e-06	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.09e-06	5.33e-06	CbGpPWpGaD
